Second, and another way in which to further test our hypothesis, was to reduce the expression of Orai1, TRPC1 and/or STIM1 by transfecting specific siRNA into B-CLL cells (1 CE+/IgM- and 2 CE+/IgM+). The gene discussed is TRPC1; the disease is B-cell chronic lymphocytic leukemia.